Pirtobrutinib: a new hope for patients with BTK inhibitor–refractory lymphoproliferative disorders

por Thompson, Philip A., Tam, Constantine S.
Publicado 2023

T-Cell Engaging Antibodies in Diffuse Large B Cell Lymphoma—An Update

por Balendran, Shalini, Tam, Constantine, Ku, Matthew
Publicado 2023

Ocular toxoplasmosis during frontline venetoclax therapy for chronic lymphocytic leukaemia – more than meets the eye

por Bennett, Rory, Lim, Lyndell L., Tam, Constantine S.
Publicado 2023

Advancements in the Treatment of CLL: The Rise of Zanubrutinib as a Preferred Therapeutic Option

por Molica, Stefano, Tam, Constantine, Allsup, David, Polliack, Aaron
Publicado 2023

Targeted Agents in the Treatment of Indolent B-Cell Non-Hodgkin Lymphomas

por Minson, Adrian, Tam, Constantine, Dickinson, Michael, Seymour, John F.
Publicado 2022

Zanubrutinib: past, present, and future

por Tam, Constantine S., Muñoz, Javier L., Seymour, John F., Opat, Stephen
Publicado 2023

Correction: Zanubrutinib: past, present, and future

por Tam, Constantine S., Muñoz, Javier L., Seymour, John F., Opat, Stephen
Publicado 2023

Colonic mucosa-associated lymphoid tissue in a renal transplant recipient: a case report

por Martin, Kylie, Taylor, Andrew, Tam, Constantine, Hill, Prue, Machet, David, Goodman, David
Publicado 2020

Impact of chronic lymphocytic leukaemia on melanoma outcomes: A retrospective case‐control study

por Jobson, Dale, McCormack, Christopher J., Mar, Victoria, Tam, Constantine, Henderson, Michael A.
Publicado 2022

Ibrutinib protects T cells in patients with CLL from proliferation-induced senescence

por Davis, Joanne E., Sharpe, Chia, Mason, Kylie, Tam, Constantine S., Koldej, Rachel M., Ritchie, David S.
Publicado 2021

P1088: COMPARISON OF BLEEDING-RELATED EVENTS IN PATIENTS WHO RECEIVED PIRTOBRUTINIB WITH AND WITHOUT ANTITHROMBOTIC AGENTS

por Lamanna, Nicole, Tam, Constantine, Jurczak, Wojciech, Kontos, Arrin, Konig, Heiko, Ruppert, Amy S., Tsai, Donald E.
Publicado 2023

Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents

por Cheson, Bruce D., Heitner Enschede, Sari, Cerri, Elisa, Desai, Monali, Potluri, Jalaja, Lamanna, Nicole, Tam, Constantine
Publicado 2017

Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemia

por Tam, Constantine S., Trotman, Judith, Opat, Stephen, Stern, Jennifer C., Allewelt, Heather, By, Kunthel, Novotny, William, Huang, Jane, Tedeschi, Alessandra
Publicado 2023

Systematic Literature Review of Economic Evaluations, Costs/Resource Use, and Quality of Life in Patients with Mantle Cell Lymphoma

por Monga, Neerav, Garside, Jamie, Davids, Matthew S., Tam, Constantine, Ward, Katherine, Fotheringham, Iain, O’Donovan, Peter, Parisi, Lori, Tapprich, Christoph
Publicado 2020

Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia

por Saulep-Easton, Damien, Vincent, Fabien B., Le Page, Melanie, Wei, Andrew, Ting, Stephen B., Croce, Carlo M., Tam, Constantine, Mackay, Fabienne
Publicado 2014

The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells

por Saulep-Easton, Damien, Vincent, Fabien B., Quah, Pin Shie, Wei, Andrew, Ting, Stephen B., Croce, Carlo M., Tam, Constantine, Mackay, Fabienne
Publicado 2015

Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia

por Tam, Constantine, Munoz, Javier, Cull, Gavin, Opat, Stephen, Allewelt, Heather, Zhang, Xiaoping, Stern, Jennifer C., Hilger, James, By, Kunthel, Cohen, Aileen, Tedeschi, Alessandra
Publicado 2023

P640: ZANUBRUTINIB VS IBRUTINIB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LYMPHOMA (R/R CLL/SLL): IMPACT ON HEALTH-RELATED QUALITY OF LIFE (HRQOL)

por Eichhorst, Barbara, Lamanna, Nicole, O’brien, Susan, Tam, Constantine, Qiu, Lugui, Yang, Keri, Wu, Ken, Salmi, Tommi, Barnes, Gisoo, Brown, Jennifer R.
Publicado 2023

Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma

por Kalac, Matko, Jain, Salvia, Tam, Constantine S., Xiao, Zhengrui, Montanari, Francesca, Kanakry, Jennifer, Huber, Bryan D., Goldfinger, Mendel, O’Connor, Owen A., Marchi, Enrica
Publicado 2023

Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression

por Admirand, Joan H., Knoblock, Ronald J., Coombes, Kevin R., Tam, Constantine, Schlette, Ellen J., Keating, Michael J., Luthra, Rajyalakshmi, Medeiros, L. Jeffrey, Abruzzo, Lynne V.
Publicado 2010